Poisson J P, Blond J P
Diabete Metab. 1985 Oct;11(5):289-94.
Streptozotocin diabetic rats were administered the same tracer dose of either [1 14C] gamma-linolenic acid or [2 14C] dihomo-gamma-linolenic acid by stomach tube seven days after streptozotocin injection. They were killed 48 hours later and the radioactivity in individual fatty acids of the kidneys and the whole animal determined by radio-gas chromatography. Results were compared to those obtained in non diabetic rats similarly prepared. With either radioactive precursor, 14C radioactivity incorporated into arachidonic acid, only as specific radioactivity of this acid, were considerably decreased in diabetic rats compared with normal rats, while the weights of renal and whole rat arachidonic acid were the same in the two groups of animals. These results suggest that, in vivo, streptozotocin diabetes causes a partial inhibition of the delta 5-desaturation of dihomo-gamma-linolenic acid, considered as a secondary step in linoleic acid metabolism, both in the kidneys and the whole rat as in the liver.
链脲佐菌素诱导的糖尿病大鼠在注射链脲佐菌素7天后,通过胃管给予相同示踪剂量的[1-¹⁴C]γ-亚麻酸或[2-¹⁴C]二高-γ-亚麻酸。48小时后将它们处死,通过放射性气相色谱法测定肾脏和整个动物个体脂肪酸中的放射性。将结果与同样处理的非糖尿病大鼠所获得的结果进行比较。无论使用哪种放射性前体,与正常大鼠相比,糖尿病大鼠中掺入花生四烯酸的¹⁴C放射性(仅作为该酸的比放射性)显著降低,而两组动物中肾脏和整个大鼠花生四烯酸的重量相同。这些结果表明,在体内,链脲佐菌素诱导的糖尿病在肾脏、整个大鼠以及肝脏中均会导致二高-γ-亚麻酸Δ⁵-去饱和作用的部分抑制,而二高-γ-亚麻酸的Δ⁵-去饱和作用被认为是亚油酸代谢的第二步。